Tooth Retention After Root Canal Treatment With Endomethasone N

Active, not recruitingOBSERVATIONAL
Enrollment

179

Participants

Timeline

Start Date

July 2, 2021

Primary Completion Date

October 21, 2026

Study Completion Date

December 21, 2026

Conditions
Dental Root Canal Obturation
Interventions
DEVICE

Endomethasone N

Endomethasone N is a powder intended to be mixed extemporaneously with a eugenol-based liquid (i.e, Endomethasone Liquid) to obtain a permanent root canal sealer. After selection of dentists, they will screen consecutively and systematically eligible patients, will send them the Patient Information Letter and will enroll them in the clinical investigation if non opposition from the patient. Patient clinical data will be recorded in an electronic Case Report Form. Pseudonymized retro-alveolar radiographies at baseline consultation and at 5 and 10 years post-obturation consultations will be recorded in the e-CRF. These radiographies will be examined by 2 independent endodontists and the results of these examinations will be recorded in the e-CRF. Site data will be collected on a Site Questionnaire with Visual Analog Scales.

Trial Locations (5)

Unknown

Private dentist office - Dr PHAM, Athis-Mons

Private dentist office - Dr LEBRET, Dax

Private dentist office - Dr ROUBINET, Montélimar

Private dentist office - Dr AUBEUX, Saint-Herblain

Private dentist office - Dr JACOB, Valence

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Septodont

INDUSTRY

NCT04945993 - Tooth Retention After Root Canal Treatment With Endomethasone N | Biotech Hunter | Biotech Hunter